论文期刊

取消

高级检索

检索历史清除

首页> Stem cell research & therapy> Exosomal miR-100-5p inhibits osteogenesis of hBMSCs and angiogenesis of HUVECs by suppressing the BMPR2/Smad1/5/9 signalling pathway.

Exosomal miR-100-5p inhibits osteogenesis of hBMSCs and angiogenesis of HUVECs by suppressing the BMPR2/Smad1/5/9 signalling pathway.

导出 OA

翻译打印收藏纠错

作者： Wu,Yang ^[1] ; Weiwen,Zhu ^[2] ; Yunfei,Yang ^[3] ; Minkang,Guo ^[1] ; Husun,Qian ^[4] ; Weiqian,Jiang ^[1] ; Yu,Chen ^[1] ; Chengjie,Lian ^[1] ; Zijie,Xu ^[1] ; Haobo,Bai ^[1] ; Tingmei,Chen ^[4] ; Jian,Zhang ^[5]

作者单位： Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. ^[1] Department of Orthopedics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. ^[2] Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. ^[3] Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University, Chongqing, 400016, China. ^[4] Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. zhangjian@hospital.cqmu.edu.cn. ^[5]

关键词 Adipocyte differentiation Angiogenesis BMPR2 Exosomes Nontraumatic osteonecrosis of the femoral head, NONFH Osteogenic differentiation miR-100-5p miRNAs

主题词动物(Animals);骨形态发生蛋白受体, Ⅱ型(Bone Morphogenetic Protein Receptors, Type II);细胞分化(Cell Differentiation);内皮细胞(Endothelial Cells);股骨头(Femur Head);股骨头坏死(Femur Head Necrosis);人类(Humans);微RNAs(MicroRNAs);骨生成(Osteogenesis);大鼠(Rats);Smad1蛋白质(Smad1 Protein)

DOI 10.1186/s13287-021-02438-y

PMID 34256859

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Stem cell research & therapy

Stem cell research & therapy

2021年12卷1期

390页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷